EUVIMEDEUVIMED entdecken
Crossref

Pharmacokinetics of Oral Minor Cannabinoids in Blood and Brain

Catherine F Moore iD, Elise M Weerts iD, Justyna Kulpa iD, Daniela Schwotzer, Wendy Dye, Jacob Jantzi, Jacob D McDonald, Timothy W Lefever, Marcel O Bonn-Miller iD

Cannabis & Cannabinoid Research · 2023-09 · 8 (1_suppl)

DOI: 10.1089/can.2023.0066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cannabis & Cannabinoid Research, online erschienen am 15.09.2023. Verfasst von Catherine F Moore und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Behavioral Biology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, U…. Hauptthemen laut MEDLINE: Brain, Plasma. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Minor cannabinoids are increasingly being consumed in oral formulations (i.e., edibles, tinctures) for medical and nonmedical purposes. This study examined the pharmacokinetics (PKs) of cannabinoids tetrahydrocannabivarin (THCV), cannabichromene (CBC), cannabinol (CBN), and delta-8-tetrahydrocannabinol (D8-THC) after the first and last oral dose during a 14-day administration period. Materials and Methods: Sprague-Dawley rats ( N =6 animals/dose, 50% female) were given an assigned dose of one of four cannabinoids (THCV=3.2–100 mg/kg, CBC=3.2–100 mg/kg, CBN=1–100 mg/kg, or D8-THC=0.32–10 mg/kg) or vehicle (medium-chain triglyceride oil) through oral gavage once daily for 14 days. Blood was collected 45 min and 1.5, 3, and 24 h following the first dose (day 1) and the last dose (day 14) of repeated oral cannabinoid treatment for PK analysis. Outcomes of interest included time to maximum concentration ( T max ), maximum concentration ( C max ), and area under the concentration versus time curve (AUC last ). Dose-normalized (DN) C max and DN AUC last were also calculated. Brain tissue was collected 24 h post-administration of the first (day 1) and the last (day 14) dose of each cannabinoid to determine concentrations in brain.

Results

All cannabinoids tested were detectable in plasma after single and 14-day repeated dosing. DN C max and DN AUC last were highest for D8-THC, followed by CBC, CBN, and THCV. There was no sex difference observed in cannabinoid kinetics. Accumulation of D8-THC in plasma was observed after 14 days of administration. THCV levels in plasma were lower on day 14 compared to day 1, indicating potential adaptation of metabolic pathways and increased drug elimination. Cannabinoids were detected in brain tissue 24 h post-administration of the first and the last dose of 17–100 mg/kg THCV, 3.2–100 mg/kg CBC, 10–100 mg/kg CBN, and 10 mg/kg D8-THC.

Conclusions

THCV, CBC, CBN, and D8-THC produced detectable levels in plasma and translocated to brain tissue after the first dose (day 1) and the last dose (day 14) of repeated oral dosing. Examination of PKs of these minor cannabinoids in blood and brain provides a critical step for informing target dose ranges and dosing schedules in future studies that evaluate the potential effects of these compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrainPlasmaFemaleRatsAnimalsMaleRats, Sprague-DawleyCannabinolCannabinoids

Stichwörter der Autor:innen

cannabichromenecannabinoidscannabinoldelta-8-tetrahydrocannabinolpharmacokineticstetrahydrocannabivarin

Substanzen

CannabinolcannabichromeneCannabinoids

Autor:innen und Institutionen

  • Division of Behavioral Biology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Canopy Growth Corporation, Smiths Falls, Ontario, Canada.
  • Lovelace Biomedical, Albuquerque, New Mexico, USA.

ORCID-Profile: Catherine F Moore, Elise M Weerts, Justyna Kulpa, Marcel O Bonn-Miller

Zitieren

APA

Moore, C. F., Weerts, E. M., Kulpa, J., Schwotzer, D., Dye, W., Jantzi, J., McDonald, J. D., Lefever, T. W., & Bonn-Miller, M. O. (2023). Pharmacokinetics of Oral Minor Cannabinoids in Blood and Brain. Cannabis & Cannabinoid Research, 8(1_suppl). https://doi.org/10.1089/can.2023.0066

Vancouver

Moore CF, Weerts EM, Kulpa J, Schwotzer D, Dye W, Jantzi J, et al. Pharmacokinetics of Oral Minor Cannabinoids in Blood and Brain. Cannabis & Cannabinoid Research. 2023;8(1_suppl). doi:10.1089/can.2023.0066

BibTeX
@article{Moore2023,
  author = {Moore, Catherine F and Weerts, Elise M and Kulpa, Justyna and Schwotzer, Daniela and Dye, Wendy and Jantzi, Jacob and McDonald, Jacob D and Lefever, Timothy W and Bonn-Miller, Marcel O},
  title = {Pharmacokinetics of Oral Minor Cannabinoids in Blood and Brain},
  journal = {Cannabis & Cannabinoid Research},
  year = {2023},
  volume = {8},
  number = {1_suppl},
  doi = {10.1089/can.2023.0066}
}
Kostenlos starten →